By Davit Kirakosyan

-- Here is your daily Pro Recap of the biggest earnings headlines you may have missed on InvestingPro since yesterday’s close. Start your free 7-day trial to get this news first.

Zoom shares soar on Q4 beat

(NASDAQ:) shares surged more than 6% premarket after the company’s exceeded Street estimates for both revenue and earnings, thanks to new enterprise customer wins.

The company posted revenue of $1.12 billion and EPS of $1.22, beating estimates of $1.10B and $0.81, respectively.

Despite concerns over softer enterprise demand due to a 15% workforce cut, enterprise customers increased by 12% year-over-year to approximately 213,000.

For Q1/24, the company guided adjusted EPS in the range of $0.96-$0.98, above the consensus of $0.85, with revenue projected to be in the range of $1.080B-$1.085B, below the consensus of $1.11B.

For the full year, the company expects adjusted EPS of $4.11-$4.18 on revenue in the range of $4.435B-$4.455B, compared to estimates of $3.67 EPS on revenue of $4.63B.

Workday shares fall despite a Q4 beat

Workday (NASDAQ:) reported its , with EPS coming in at $0.99, above the consensus of $0.89. Revenue increased 19.6% year-over-year to $1.65B, beating the consensus estimate of $1.63B. Shares fell more than 2% premarket.

The company now expects full-year subscription revenue of $6.525B-$6.575B (up 17%-18%) and a non-GAAP operating margin of 23.0%.

Furthermore, the company appointed Sayan Chakraborty as co-president, Robynne Sisco as vice chair, and elected Mark Hawkins as an independent director of its Board of Directors.

Occidental Petroleum posts a Q4 miss, announces new buyback & hikes dividends

Occidental Petroleum (NYSE:) reported its , with EPS of $1.61 missing the consensus estimate of $1.81. Revenue came in at $8.33B, worse than the consensus estimate of $8.37B.

The company said it would start a new $3B share repurchase program after completing a $3B program. In addition, the company also hiked its dividend by 38%.

Hims & Hers Health shares jump on Q4 beat

Hims & Hers Health (NYSE:) shares surged more than 10% premarket after the company posted , with EPS of ($0.05) coming in better than the consensus of ($0.06). Revenue was $167.2 million, better than the consensus estimate of $160.8M.

For Q1/23, the company expects revenue in the range of $175M-$180M, better than the consensus of $163M. Full-year revenue is expected in the range of $735M-$755M, compared to the consensus estimate of $727M.

The company also provided financial targets for its fiscal 2025, expecting revenue of at least $1.2B and adjusted EBITDA of at least $100M.

Santander plans to give back half of the profits to shareholders over 3 years

(BME:) (NYSE:) shares gained more than 4% premarket on the NYSE after the it plans to increase shareholder payouts through cash and share buybacks, returning half of its profits over the next three years. The bank expects higher revenue driven by customer growth and higher interest rates in some of its core markets to achieve its targets.

The company aims to achieve a return on tangible equity of 15-17% over the period from an underlying profit of 13.37%. Its updated payout policy for the years 2023-2025 will distribute 50% of consolidated attributable profits, except for non-cash and non-capital ratios impact items. This represents an increase from the current 40%.

The company expects an increase in its global customer base by 40M to around 200M. The bank will raise its total cash dividend per share for 2022 to €0.1178 (€1 = $1.0611) and has authorized an additional share buyback program of €921M ($974.8M) after obtaining regulatory authorization.